Welcome to the UPF Digital Repository

Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome?



Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome?

Thumbnail
Document Type: Article
Version: Published version
Date: 2017
This document is associated with a Creative Common license © The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Thumbnail

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking